News
Novo Nordisk’s stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes ...
The new price, which also applies to Lilly's type 2 diabetes medicine that has the same name, is effective from September ...
The manufacturers of a new weight-loss drug recently rolled out by the NHS are upping their prices by 170%. Eli Lilly is ...
Eli Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro for people who buy the drug ...
Broadcom rides AI growth and VMware integration, Philip Morris pushes smoke-free transition, while Novo Nordisk grapples with ...
At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Eli Lilly will increase the UK price of its Mounjaro treatment by 170% to match European markets. Despite Novo Nordisk's ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Semaglutide and similar peptide drugs bind the G-protein coupled GLP-1 receptor to transfer chemical signals from outside the ...
Drugmakers Lilly and Novo have faced criticism about the cost of the treatments, which carry a list price of about $1,000 for a month's supply.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results